In Brief
Natural killer cells are present in the human decidua, regulating trophoblast invasion and angiogenesis. Here, Gamliel et al. report on a special subset of human decidual natural killer cells, which ''remember'' pregnancy and better support subsequent pregnancies. This might explain why first pregnancies are at increased risk of developing diseases of poor placentation.
INTRODUCTION
Natural killer (NK) cells were first discovered for their ability to kill tumor cells, and later found to also kill pathogen-infected cells (Koch et al., 2013) . Though part of the innate immune system, several reports suggest that NK cells in mice, monkeys, and humans possess adaptive-like properties (Gumá et al., 2004; (Netea et al., 2016) . In mice, adaptive immune-like features including long-lived memory cells, clonal expansion, recall response and antigen specificity have been observed in several experimental systems (Keppel et al., 2013; Paust et al., 2010; Sun et al., 2009) . In humans, NK cell ''memory'' has been mainly demonstrated by the finding that a subset of human peripheral blood NK (pbNK) cells expressing the receptor CD94-NKG2C expands following human cytomegalovirus (HCMV) infection (Gumá et al., 2004) . ''Memory'' NK cells can also be induced by cytokines such as interleukin-12 (IL-12), IL-15, and IL-18 (Berrien-Elliott et al., 2015; Cooper et al., 2009) .
NK cells recognize their targets using an array of inhibitory and activating receptors (Seidel et al., 2012) . The majority of the NK inhibitory receptors bind MHC class I molecules, although inhibitory receptors that do not recognize MHC class I, such as TIGIT (Stanietsky et al., 2009 ) also exist. LILRB1, a member of the leukocyte immunoglobulin-like receptor (LIR) family, is one of the NK inhibitory receptors (Koch et al., 2013) , which recognizes a broad spectrum of MHC class I proteins, with preferential binding to HLA-G. HLA-G is a non-classical MHC class I protein expressed almost exclusively on extravillous trophoblast cells that are in direct contact with decidual NK cells during pregnancy (Rizzo et al., 2011) .
Some of the inhibitory receptors have activating counterparts. For example, NK cells express a heterodimer receptor composed of CD94-NKG2A that recognizes the non-classical MHC class I protein HLA-E (expressed on almost all human cells, including the extravillous trophoblasts) and acts as an inhibitory receptor (Valé s-Gó mez et al., 1999) . HLA-E preferentially presents leader peptides of HLA-G (Llano et al., 1998) . In contrast, when CD94 heterodimerizes with NKG2C, it activates NK cells upon interaction with HLA-E, although this interaction is of low affinity (Valé s-Gó mez et al., 1999) .
Different tissue-resident subpopulations of human NK cells exist throughout the body, displaying unique phenotypic and functional properties (Bjö rkströ m et al. , 2016) . One of the most fascinating tissue-resident subsets of NK cells, termed decidual NK (dNK) cells, is found at the maternal fetal interface (decidua) in direct contact with the placenta. The origin of these dNK cells is still unclear and it is thought that the dNK population is a heterogeneous: some migrate from the peripheral blood while other originated from local endometrial NK cells (Keskin et al., 2007; Manaster et al., 2008; Vacca et al., 2011) . dNK cells comprise 50%-70% of decidual lymphocytes during the first trimester (Koopman et al., 2003) and are in direct contact with extravillous trophoblast cells and spiral arteries (Hanna et al., 2006) . Functionally, dNK cells display limited cytotoxicity and instead produce cytokines, growth factors, and angiogenic factors needed to appropriately remodel the maternal spiral arteries, promoting angiogenesis and attracting invasive trophoblasts to the decidua (El Costa et al., 2009; Hanna et al., 2006) . Phenotypically, dNK cells are similar to the minority population of pbNK cells characterized as CD56 bright CD16 neg (Koopman et al., 2003) . dNK cells express most of the activating and inhibitory receptors expressed by the pbNK cells (Jabrane-Ferrat and Siewiera, 2014) . However, dNK cells also express receptors that are not expressed on pbNK cells, and the function of several receptors in dNK cells is different as compared to pbNK cells. For example, naive dNK cells express the activating NK receptor NKp44 ( (Hanna et al., 2006; Kopcow et al., 2005) , although others (Male et al., 2011) report no expression, which is only found on pbNK cells following activation (Vitale et al., 1998) . 2B4, which is a co-activating receptor in human pbNK cells, functions as an inhibitory receptor in the decidua (Vacca et al., 2006) . Finally, LILRB1, which is an inhibitory receptor in pbNK cells, is an activating receptor in the decidua (Li et al., 2009) . Observations indicate that the uterus and placental bed differ between multigravidae (women who were previously pregnant and are currently pregnant) and primigravidae (women who are currently pregnant for the first time). Pregnancy appears to be enhanced in multigravidae in terms of vascularization and angiogenesis, as deeper and earlier endovascular trophoblast invasion has been observed in repeated pregnancies . Importantly, conditions linked with deficient placentation referred to as the ''great obstetrical syndromes'' (e.g., IUGR, intrauterine growth restriction; SGA, small for gestational age), are found at lower frequencies in repeated pregnancies (Kozuki et al., 2013) . Primigravidity is a risk factor for development of preeclampsia, a disease characterized by poor placental perfusion due to impaired placental development (Karumanchi et al., 2005) . Preeclampsia affects 5%-10% of first pregnancies, but far fewer repeated pregnancies, and an unbalanced innate immunity is suggested to be involved in the etiology of this disease (Yeh et al., 2013) . Furthermore, anatomical evidence shows that the uterine anatomy does not completely return to its original state post pregnancy (Khong et al., 2003) . Consequently, all of these observations indicate that placental development in humans is more efficient in subsequent pregnancies. The mechanisms behind are yet unknown.
Given our knowledge regarding dNK cells and their importance in pregnancy, along with the ability of NK cells to exhibit features of adaptive immune cell memory, we hypothesized that dNK cells may have features of memory which contribute to better supporting repeated pregnancies.
Here we have described a specific population of dNK cells that is detected in multigravid women. We demonstrated that these cells have enhanced production of IFN-g and VEGFa. We termed these cells ''Pregnancy Trained dNK cells'' (PTdNKs) and suggest that these cells remember the first pregnancy and better assist future gestations.
RESULTS

An NKG2C
hi Population Is Expanded in the dNK Cells of
Multigravid Women
Given that dNK are the most abundant leukocytes in the uterus in early pregnancy (Koopman et al., 2003; Manaster et al., 2008) , the realization that NK cells possess adaptive immune-like properties, and the fact that repeated pregnancies show improved placentation, we hypothesized that human dNK cells remember pregnancy and might respond more efficiently in subsequent pregnancies. To test this, we isolated decidual lymphocytes from first trimester deciduae of primigravid and multigravid women and stained them for CD56 and CD3 expression. As can be observed in Figure 1A , most of the lymphocytes in the decidua were CD56 bright NK cells. Because NK cell memory in the peripheral blood is associated with expansion of cells expressing specific receptors (Gumá et al., 2006) , we stained dNK obtained from decidua of primigravid and multigravid women for various NK cell receptors including NKp46, NKp44, NKp30, NKG2D, CXCR3, CXCR4, and NKG2C. As compared to primigravid decidua ( Figure 1B) , we observed expansion of a specific subset of dNK cells characterized by high expression of NKG2C in multigravid women ( Figure 1C ), whereas no changes were observed in the expression of other receptors tested (data not shown). For reasons detailed below, we named these NKG2C hi cells ''Pregnancy Trained dNK cells'' (PTdNKs).
The Expansion of the NKG2C hi Population Is Unique to dNK Cells, and Is Independent of Gravidity, Week of Pregnancy, or Maternal Age Expansion of NKG2C hi pbNKs was previously shown to occur following HCMV infection (Gumá et al., 2004) . About 80% of all women in our local population are HCMV positive and the percentage of HCMV positive women increases with age (Weisblum et al., 2015) . Therefore, in Figure 1D , as well as in all of the following figures, we included only HCMV seropositive women (Tables S1-S9 ). Figure 1D summarizes the percentage of NKG2C hi cells found in the first cohort of women that we analyzed (black for primigravidae, colored for multigravidae). The average percentage of the NKG2C hi cells in the primigravid group was 2.93 (range: 0.19-5.42), while the average percentage in the multigravid group was 17.0 (range: 5.9-31.72) ( Table S1 ). Expansion of NKG2C hi cells was observed in almost all multigravid women and was independent of gravidity ( Figure 1D ). To test whether the NKG2C hi expansion was unique to dNKs or is also found on other decidual lymphocytes, we assayed expression of NKG2C on T cells of the women tested. Expression of NKG2C on T cells isolated from primigravid and multigravid women did not differ ( Figure 1D , white columns). The NKG2C hi expansion was independent of week of pregnancy ( Figure 1E , Table S2 ) and maternal age ( Figure 1F , Table S2 ). Importantly, the NKG2C hi expansion was observed even if previous pregnancies did not reach term; i.e., gravidity R 2, parity zero ( Figure 1G , Table S3 ). (Figures  2A-2I) . We divided these genes into groups according to pathway or function, namely: NK cell activation (Figure 2A ), chemokine receptors ( Figure 2B ), interleukins ( Figure 2C) Table S1 .
NKG2C
(E and F) Percentages of NKG2C hi expression in the multigravid decidual samples relative to the week of pregnancy (E, week 6-14, please also see Table S2 ) or maternal age (F, ages 24-43, please also see Table S2 ).
(G) Percentages of NKG2C hi expression in multigravid women who did not complete any of their previous pregnancies (black, gravidity R 2 while p = 0, arranged according to the gravidity number), as compared to primigravid samples (white). Mean percentages are indicated. **p % 0.01. Please also see Table S3 .
(C-Type Lectins, Figure 2D ), Fc receptors ( Figure 2E ), chemokines ( Figure 2F ), growth factors and immune modulation (Figure 2G) , hormone regulation ( Figure 2H ), and others ( Figure 2I ). In each group, log 2 fold change for each gene is indicated and the expression of some of the elevated genes was verified by qRT-PCR (tested on an independent pooled sample, Table S4 , middle list). The RNA expression of the receptors NKG2C, CCR10, FCRL5, FCGR2, and LILRB1 was found to be upregulated in NKG2C hi cells as compared to NKG2C neg cells and the expression of these receptors was validated by flow cytometry. CCR10, FCRL5, and FCGR2 were indeed found to be upregulated on a subset of the NKG2C hi population ( Figure 2J , Table S4 ). KIR2DL4 that is reported to bind HLA-G (Boyson et al., 2002) , was not upregulated (data not shown). LILRB1 was highly expressed on NKG2C hi cells obtained from multigravid women as compared to primigravid women (Figures 2K and 2L, respectively) . Quantification of the staining (MFI) on the NKG2C hi and the NKG2C neg cells from eight multigravid decidua samples (Table S4) is shown in Figure 2M . Thus, we conclude that PTdNKs express a unique transcriptome and are characterized by high expression of NKG2C and LILRB1.
IFNG and VEGFA Loci Are More Accessible in the PTdNKs, Leading to Increased Production and Secretion To further clarify the uniqueness of the PTdNKs, we performed ATAC-seq (assay for transposase-accessible chromatin sequencing) comparing NKG2C hi to NKG2C neg cells pooled from four multigravid samples (Table S5 , middle panel). We focused mainly on the chromatin status of two important growth factor genes: VEGFA, shown to be produced by human dNK cells and supporting vascular formation (Hanna et al., 2006) , and IFNG, shown to be essential for angiogenesis among other functions (Ashkar and Croy, 1999) As seen in Figure 3A , IFNG and VEGFA were found to have increased accessibility in NKG2C hi compared to the NKG2C neg cells. Because LILRB1 and NKG2C defined the expanded PTdNK population, and since both receptors have been previously associated with NK cell memory (Cerwenka and Lanier, 2016) , we next investigated whether engagement of these receptors results in increased IFN-g or VEGFa secretion. For this we employed the MHC class I negative cell line 721.221 ( Figure 3B ), transfected to express HLA-E, the ligand of CD94-NKG2C (Figure 3C) , or HLA-G, a ligand of LILRB1 ( Figure 3D ). We next iso- Table S4 .
lated and pooled dNK cells from at least eight primigravid and eight multigravid women (Table S6) In the absence of IL-15, or when no targets were added, little or no secretion of IFN-g was observed (data not shown). IFN-g secretion was observed when either 721.221-HLA-E or -HLA-G cells were incubated with dNK cells obtained from primigravid women ( Figure 3F ). However, when dNK cells obtained from multigravid women were used, IFN-g secretion was significantly enhanced ( Figure 3G ). To demonstrate that the IFN-g secretion is indeed due to NKG2C interaction with HLA-E and LILRB1 interaction with HLA-G, we blocked NKG2C (with anti CD94) or LILRB1. Blocking almost completely abolished IFN-g secretion in both cases (Figures 3F and 3G) .
To test whether VEGFa is also secreted at higher amounts from PTdNKs, we pooled samples from primigravid or multigravid women (Table S7 ) and incubated dNK cells with 721.221-HLA-E or 721.221-HLA-G (721.221 served as control) in the presence of rhIL-15. Secretion of VEGFa was seen in the primigravid women only following incubation with HLA-E, but not with HLA-G ( Figure 3H ). When dNK cells from multigravid women were used, VEGFa secretion was significantly enhanced upon interaction with HLA-E and HLA-G ( Figure 3I ). We again performed blocking experiments using the mAbs mentioned above and observed partial, yet significant, inhibition of VEGFa secretion ( Figures 3H and 3I ).
The increased secretion of IFN-g and VEGFa could be explained either by the presence of more NKG2C hi cells in the multigravid dNK cells' samples or by greater secretion per cell of both cytokines. To test this, we used equal numbers of NKG2C hi cells from primigravid and multigravid women (Table S7) , incubated each of them with 721.221-HLA-E (because VEGFa was not detected following incubation of primigravid NKG2C hi cells with HLA-G, Figure 3H ), and performed intracellular flow cytometry staining. We observed that NKG2C hi cells obtained from multigravid women produced more IFN-g ( Figure 3J ) and VEGFa ( Figure 3K ) per cell.
VEGFa Secreted by PTdNKs of Multigravid Women Enhances Vascularization and Tumor Growth
To test the functionality of the secreted growth factors, we employed ex vivo ( The range in the chromosome is shown regarding IFN-g and VEGFa as well as the direction of gene transcription (the amplitude and width represent the accessibility of the region). Please also see Table S5 . , Brefeldin was added for 10 hours. Then, membrane protein staining (CD56, CD3, CD16, NKG2C) followed by intracellular staining for cytokines was performed. The MFI (median florescent intensity) is indicated. Each plot represents one out of two independent experiments. The setting of the coordinates along the log scale in either the IFN-g (J) or VEGFa (K) is based on the specific isotype control matching. Please also see Table S7 . models. We initially prepared aortic rings, isolated from C57BL/6-Tg [Act-EGFP] mice . Supernatants obtained from dNK of primigravid and multigravid women, incubated with 721.221-HLA-E or 721.221-HLA-G, in the presence or absence of the appropriate antibodies (same conditions used in Figures  3F-3I ), were placed on the aortic rings. Limited sprouting was observed when PBS (data not shown) or primigravid supernatants ( Figure 4A ) were used. In contrast, marked sprouting was observed in the multigravidae-derived supernatants ( Figure 4B ), and this sprouting was partially blocked when the appropriate antibodies were included in the assay (anti CD94 or anti LILRB1, Figure 4B) . A summary of the results is presented in Figure 4C , depicting the sprouting index (taking into account the numbers and length of the sprouting capillaries). To directly demonstrate Table S7 . **p % 0.01. (E-I) JEG3 cells were injected subcutaneously into SCID-Beige mice. 14 days later, when the tumors became measurable, mice were injected with supernatants obtained from the experiments presented in Figure 3I Table S7 .
that the sprouting was due to VEGFa, we pre-incubated the supernatants obtained from the multigravid dNK cells with Avastin (Bevacizumab, anti VEGFa) and observed a significant reduction ( Figure 4D ). We next aimed to test the functionality of dNKs from primigravid and multigravid women in an in vivo model. We employed SCID-Beige mice (that lack NK, T, and B cells and therefore accept human tumors), and injected them subcutaneously with the JEG3, choriocarcinoma-derived JEG3 cells. When the tumors were palpable, we injected PBS (used as control, Figure 4E ) or supernatants obtained from dNK cells of multigravid women (Table S7) , which had been incubated with 721.221-HLA-E ( Figure 4F ), 721.221-HLA-E with anti-CD94 (Figure 4G ), 721.221-HLA-G ( Figure 4H) , and 721.221-HLA-G with anti-LILRB1 ( Figure 4I) . The next day, we determined tumor sizes, repeated the injections, and measured tumor size again in the following day. Importantly, tumor volume was proportional to the amount of growth factors secreted (summarized in Figure 4J ).
The greatest secretion of VEGFa was observed upon interaction of dNK from multigravid women with 721.221-HLA-E ( Figure 3I ) and accordingly tumors injected with these supernatants were indeed the largest (Figures 4F and 4J ). Upon blocking of the NKG2C-HLA-E interaction, tumor volume was reduced ( Figures  4G and 4J ). Large tumors were also observed when supernatants obtained from dNK interaction with HLA-G were used ( Figures 4I  and 4J ) and tumor volumes were reduced upon blocking of this interaction ( Figures 4E-4I summarized in 4J) . To demonstrate that the increased tumor growth is due to VEGFa, we blocked VEGFa by pre-incubation of the supernatants with Avastin and observed markedly reduced tumor growth ( Figure 4K ). Tables S5 and S9. expression of NKG2C and LILRB1 on NK cells in the peripheral blood or in the endometrium was different between nulligravidae (gravidity, G = 0) and multigravidae (G R 1). To test this, we compared the percentages of NKG2C hi cells on pbNK cells obtained from both groups ( Figure 5A for the CD56 dim CD16 pos and 5B for the CD56 bright CD16 neg ). Information on the samples is provided in Table S8 . Although not statistically significant, we observed an increase in NKG2C expression on both peripheral blood populations in multigravid women ( Figures 5A and 5B) . However, expression of NKG2C on the pbNKs of some multigravid women was very low (Figures 5A and 5B) . No difference in LILRB1 expression was observed between the groups in the peripheral blood (data not shown).
NKG2C was shown to be expressed on menstrual blood NK cells (Ivarsson et al., 2017) . We therefore also compared the NKG2C expression on menstrual blood NK cells obtained from women who were previously pregnant and those who had not (Table S9) . We observed a significant expansion of NKG2C hi cells in menstrual blood of women who were pregnant and didn't find low levels of NKG2C in any women who had been pregnant ( Figure 5C ). Moreover, LILRB1 expression was also found to be increased on the NKG2C hi endometrial NK cells of women who had been pregnant compared to those who had not ( Figure 5D ). To test whether we could convert peripheral blood or endometrial NK cells into PTdNKs, we initially incubated these cells with cells expressing HLA-G and HLA-E under various conditions. Such conversion was unsuccessful. While, it is still possible that we were not able to fully recapitulate the microenvironment of pregnancy, these results suggest that direct triggering of LILRB1 and NKG2C might not be enough to obtain the PTdNK phenotype.
All women included in the menstrual cohort ( Figures 5C and  5D ), reported no use of hormonal contraceptives. Three women with gravidity zero (data given in Table S9 ) who reported use of a locally hormonal contraceptive named Nuvaring (an estradiol vaginal ring) were analyzed separately ( Figures 5E and 5F ). Importantly, as seen in Figure 5E , increased percentages of NKG2C hi cells were found among the endometrial NK cells obtained from these women, which was far greater than the nulligravid samples ( Figure 5C ), while LILRB1 remained low (Figure 5F ). This expansion did not occur in the pbNK cells of these women (data not shown). Combining all of these results together, Tables S1 and S8 .
(E-G) Summary of the percent expression of the indicated receptors on the NKG2C hi cells isolated from menstrual NK cells from women who had never been (E, n = 5-7), had been pregnant with at least one completed pregnancy in the last 5 years (F, n = 5-9), and had never been pregnant but use Nuvaring (G, n = 3). Please also see Table S9 for information and numbers of women included in each.
we hypothesize that the PTdNK cells precursors might be found in the endometrium between pregnancies. To further test this hypothesis and to test whether the epigenetic signature of the dNK cell populations is similar to that of endometrial NK cells, we performed ATAC-seq on the NKG2C hi cells obtained from endometrial NK cells and decidual NK cells, comparing nulligravid, primigravid, and multigravid samples (epidemiological data is given in Tables  S5 and S9 , all women included reported no use of hormone contraceptives, full ATACseq data is available in GEO). The epigenetic signature of endometrial NKG2C hi NK cells obtained from nulligravid women was different as compared to the three other populations (Figure 5G , heatmap of 230 top changing peaks). The decidual and the NKG2C hi endometrial NK cells obtained from multigravid women had more similar epigenetic signatures, but were still different from each other ( Figure 5G ). The IFNG and VEGFA enhancers, shown to differ between the NKG2C hi and NKG2C neg of multigravid dNK cells ( Figure 3A) , did not differ in genomic accessibility between the NKG2C hi samples. Finally, we characterized the expression of various receptors reported to be involved in HCMV-induced memory (Gumá et al., 2004; Hwang et al., 2012; Lopez-Vergè s et al., 2011) in all NKG2C
hi cells studied here ( Figures 6A-6G , representative flow cytometry; dot plots are shown in Figures S1 and S2) . These include NKp30, NKp46, and FcεRIɤ (reported to be downregulated, Gumá et al., 2004; Romee et al., 2016; Zhang et al., 2013) as well as CD57 and KIR2DL2-3 (reported to be upregulated, Foley et al., 2012; Lopez-Vergè s et al., 2011) . DNAM1, which has been shown to be involved in murine NK cell memory in response to MCMV (Nabekura et al., 2014) was also included (Table S10 summarizes the receptor profile and function of the three human ''memory'' NK cells types).
We observed an almost identical receptor repertoire in the NKG2C hi NK cells obtained from the decidua of primigravid (Figure 6A ) and multigravid ( Figure 6B) women. Both populations did not express CD16, CD57, or DNAM-1. Also, FcεRIɣ, NKp30, and NKp46, which were downregulated on HCMV-induced memory pbNK cells, are expressed by PTdNKs, and a subset of the expanded NKG2C
hi dNK population expresses KIR2DL2-3 and NKp44. Moreover, high similarity was seen regarding the nulligravidae and multigravidae menstrual NKG2C hi populations and also in women that use Nuvaring (Figures 6E-6G) .
In light of these data, we conclude that PTdNKs have a unique transcriptome as well as epigenetic signature. PTdNK are characterized by increased expression of LILRB1 and NKG2C, and not by other ''memory'' related receptors. We propose that the precursors of PTdNKs are found in the uterus between pregnancies. While pregnancy occurs, they are converted to be PTdNKs under the influence of the uterine microenvironment.
DISCUSSION
We have demonstrated here that a unique dNK cell population, characterized by increased NKG2C and LILRB1 expression, is found in the decidua of multigravid women. Previous reports indicate that the RNA of NKG2C (Koopman et al., 2003) , as well as that of LILRB1 (Apps et al., 2007; Marlin et al., 2012) , is expressed in dNK. Here we show that the expression of NKG2C and LILRB1 is mostly confined to the NKG2C hi decidual ''memory'' NK cells, that we termed PTdNKs. Transcriptome analysis, as well as epigenetic characterization, revealed that PTdNKs are indeed a unique, tissue-specific population. We further show that PTdNKs secrete more IFN-g and VEGFa upon interaction of NKG2C with HLA-E and LILRB1 with HLA-G. The VEGFa obtained from multigravid (but not from primigravid) women, was functional using an ex vivo aortic sprouting model and in an in vivo tumor growth model. This suggests that PTdNKs can better support vascularization, a critical component in development of the placental bed. We also demonstrated that PTdNKs produce increased amounts of IFN-g upon interaction of NKG2C with HLA-E and LILRB1 with HLA-G. IFN-g is secreted during early pregnancy by both dNK and trophoblast cells (Croy et al., 2003; Paulesu et al., 1994) and human trophoblast cells express IFN-g receptors throughout pregnancy (Banerjee et al., 2005) . Importantly, early work in mice from the Croy group demonstrated, as mentioned above, that IFN-g plays a major role in initiation of endometrial vasculature remodeling, angiogenesis at implantation sites, and maintenance of the decidua (Ashkar et al., 2000; Murphy et al., 2009) .
In agreement with previous research (Li et al., 2009) hi populations, no differences were observed. This suggests that additional mechanisms, other than enhanced accessibility, exist in the multigravid NKG2C hi dNK cells that are responsible for the increased production of IFN-g and VEGFa.
We also attempted to investigate where the PTdNK precursors reside post first pregnancy. Expression of both NKG2C and LILRB1 (the two receptors that identify the PTdNKs) was significantly increased in multigravid menstrual blood NK cells. In contrast, in the peripheral blood of the multigravid group, expression of neither receptor was significantly elevated. Thus, we hypothesize that the endometrium contains the PTdNK precursors, although the entire repertoire of receptors shown to be involved in memory was not identical between the menstrual blood NK cells and PTdNKs. To test this hypothesis, we tried converting the endometrial NK cells into PTdNKs via direct triggering of NKG2C and LILRB1 by their appropriate ligands and were unsuccessful. Although it is possible that we did not fully imitate the right conditions that exist during pregnancy in these experiments, these efforts suggest that the pregnancy environment might convert the endometrial NK cells into PTdNKs. Indeed, we observed a massive expansion of NKG2C hi cells in the menstrual blood, but not in the peripheral blood, of women who were not pregnant that use Nuvaring. Thus, although it is still possible that the pbNK cells contain the PTdNK precursors, we think it is likely that these precursors are found in the endometrium. We next performed ATAC-seq on NKG2C hi NK cells obtained from the decidua of multigravid and primigravid women and from the menstrual blood of multigravid and nulligravid women. The first notable observation was that following pregnancy the epigenetic signature of the menstrual blood NK cells was completely altered. The second observation was that the three NKG2C hi populations (dNK cells from multigravid and nulligravid women and endometrial NK cells from multigravid women) were similar but not identical. The third observation was that no differences between the various NKG2C hi populations were observed in the locus accessibility of IFNG and VEGFA. Taken together, we suggest that PTdNK precursors are likely found in the uterus, and upon pregnancy, are converted to PTdNKs.
We propose that the PTdNKs represent a special type of innate memory. As far as we know, innate ''memory'' has so far been documented in response to specific challenges or viral infection along with cytokine induced memory. The pregnancyrelated NK memory cells identified here might represent the first example of improved function of NK cells that occurs under healthy physiological conditions.
PTdNKs are substantially different from other ''memory'' NK cells including those that respond to HCMV and cytokineinduced ''memory'' NK cells. All three ''memory'' NK cells secrete higher amounts of IFN-g, yet PTdNKs uniquely show higher secretion of VEGFa as well.
Our findings may also provide an explanation as to why complications of pregnancy, especially the ''great obstetrical syndromes'' originating in deficient placentation, are less frequent in repeated pregnancies (Kovo et al., 2013) . It is possible that because decidual NK cells function less efficiently in first pregnancies, if a challenge occurs (even one unrelated to NK cells directly, such as preeclampsia), it becomes harder to control or to compensate for. Indeed it was reported that NKG2C expression is altered in the peripheral blood of preeclampsia patients, however contradicting results have been obtained as some reported decreased expression (Bachmayer et al., 2009) , while others saw increase (Bueno-Sá nchez et al., 2013). We suggest that artificial expansion during first pregnancy or manipulation of NKG2C
hi menstrual blood NK cells during the menstrual cycle may help in cases of inadequate placentation.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Decidual samples from healthy women who underwent elective first trimester terminations of normal pregnancies Deciduae were obtained from elective first trimester (6-14 weeks) termination of normal pregnancies. Average age of the women was 22 for primigravid women (range 18-27), and 34 for multigravid women (24-45). The institutional review board of the Hadassah Hospital Medical Center approved the use of decidual material, according to the principles of the Helsinki Declaration (0423-10-HMO) and informed consent was obtained from all women. All women were healthy and pregnancies were terminated due to social reasons. A fetal ultrasound was performed prior to all elective terminations to establish the fetal age by means of CRL (crown-rump length) and fetal viability. Any fetal anomalies with known or suspected placental disorders or malformations were not included. Epidemiological data of all samples included is found in Tables S1-S7, mentioned in relation to each figure.
Peripheral and menstrual blood of healthy women who were pregnant or not Blood was taken from healthy, HCMV positive female donors (age 20-43), who had given birth in the past 5 years. Number of previous pregnancies is detailed in Table S8 . Healthy, HCMV-positive female donors (age 22-38), who gave birth in the past 5 years, with regular menstrual cycles and with no known gynecological diseases were included in the menstrual blood analysis. None of the women reported using hormone contraceptives, except the women who use Nuvaring who were analyzed separately. Number of previous pregnancies is detailed in Table S9 . The institutional review board of the Hadassah Hospital Medical Center approved the use of endometrial material, according to the principles of the Helsinki Declaration (0335-17-HMO) and informed consent was obtained from all women. The peripheral blood collecting samples is part of the 0423-10-HMO approval.
SCID-Beige and EGFP mice
Four-week-old SCID-Beige female mice (5-6 mice per group) and 3 months old C57BL/6-Tg [Act-EGFP] mice (6 rings per condition) were used.
METHODS DETAILS
Isolation of human decidual lymphocyte subsets Decidual tissues were rinsed of blood clots and trimmed to 1mm pieces in 1xPBS supplemented with 1mM of penicillin-streptomycin. Tissue pieces were then transferred to a 50 ml tube with 15 ml warm RPMI-1640 and subjected to enzymatic digestion with 0.1 mg per 1 ml DNase type I (Roche) and 1 mg per 1 ml Collagenase IV (Warthington). Digestion was performed for 20 minutes in a 37 C water bath with occasional vigorous shaking. After collection of the supernatant, the remaining tissue pieces were treated with two additional rounds of digestion. The supernatants obtained from three digestion rounds were passed through a 40-mm cell strainer. The collected cells were washed twice in RPMI-1640, resuspended in 10 ml of DMEM medium containing10% heat-inactivated fetal calf serum (FCS, Sigma-Aldrich) and 1% each of non-essential amino acids, L-glutamine, sodium pyruvate and penicillinstreptomycin (all from Biological Industries) and plated on a sterile 10cm cell culture dish (Falcon). After overnight incubation at 37 C in a humidified 5% CO2 incubator, only the non-adherent cells were collected, and washed twice with sterile RPMI-1640. Cells were then subjected to sterile density gradient separation by Ficoll.
Isolation of peripheral blood lymphocyte subsets and HCMV serology typing PBMCs were purified from fresh blood samples, derived from healthy female donors, on a Ficoll gradient. Screening for HCMV IgG antibodies in the plasma was performed using ImmunoComb II CMV IgG Kit (Orgenics 60460002). All samples used here were from HCMV-positive women.
Isolation of endometrial lymphocytes
Menstrual blood was obtained from women with regular menstrual cycles and with no known gynecological diseases using a menstrual cup and collection tubes. Collection tubes contained 10 mL RPMI (10% Fetal Calf Serum, 1% Penicillin, Streptamycin and 40 U ml-1 heparin). Menstrual blood was collected during menstruation days 1 and 2. Mononuclear cells from menstrual blood were isolated on a sterile density gradient separation by Ficoll (lymphoprep). Net menstrual blood volumes varied between 2 and 25 ml. None of the women reported using hormonal contraceptives, except the women using Nuvaring who were analyzed separately. The number of previous pregnancies is detailed in Table S9 .
Multiple color flow cytometry-based staining
The conjugated mouse anti-human mAbs used for extracellular flow cytometry staining are listed in the key resource table. Antibodies used in intracellular staining for FcεRIg, VEGF (biotin 2mg per well, followed by 647 secondary) and IFN-g was done using the BD Cytofix-Cytoperm Intracellular Staining kit, according to the manufacturer's instructions. All stainings were analyzed by flow cytometry software (Kaluza Analysis software and FCS Express 4). Intracellular staining of the primigravid and multigravid dNK were performed by incubation of an equal number of NKG2C hi cells obtained from primigravid or multigravid women with 75,000 cells per well of 721.221-HLA-E cells in the presence of (0.1mg per 1ml) rhIL-15 (BLG-570302). Following incubation of 48 hours (in the case of IFN-g) or 72 hours (in the case of VEGFa), 0.2 mg per well Brefeldin A (Golgi-plug) (1ml per ml in concentration of 1 million cells per well) was added for 10 hours and membrane staining was done using the BD Cytofix-Cytoperm Intracellular Staining kit (PMG555028) according to the manufacturer's instructions.
Expression analysis of NKG2C
hi and NKG2C neg cells of decidual samples from multigravidae (RNAseq)
RNA isolation, library construction and sequencing Five different multigravid decidual samples were treated as described above for lymphocyte separation and then pooled. dNK cells were purified from the pooled sample by EasySep Human NK Cell Enrichment Kit (STEMCELLS). Flow cytometry based dNK cell sorting (BD FACSAria II flow cytometer) was done in order to purify CD56 bright NKG2C hi and CD56 bright NKG2C neg subsets. The conjugated mouse anti-human mAbs (anti-CD56 and anti-NKG2C) were used for cell sorting as well as matching conjugated isotype controls. Subset purity was routinely checked and found to be higher than 95%. The total RNA extract was purified from each population by Quick-RNA MiniPrep (ZYMO). The libraries were constructed using the TruSeq RNA V2 kit by Illumina and sequenced on a NextSeq 500 machine using NextSeq 500 High Output V2 Sequencing Kit (75 cycles) #FC-404-2005.
Processing and Analysis of RNAseq Data
Raw reads were quality-trimmed with a quality threshold of 32. Then, adaptor sequences were removed using Trim Galore (version 0.3.7). Reads that became shorter than 15 bases were removed. The remaining reads were further filtered to remove very low-quality reads, with a quality threshold of 20 at 90 percent or more of the read's positions (FASTX, version 0.0.14). The processed fastq files were mapped to the GRCh38 human genome using TopHat (v2.0.13), with up to 5 mismatches. Quantification, normalization and log fold change calculations were done with the Cufflinks package (version 2.2.1). All data have been deposited in the GEO database.
Quantitative PCR (qRT-PCR) mRNA was isolated using Quick-RNA MiniPrep (ZYMO). Reverse-transcription to cDNA was performed using M-MLV Reverse Transcriptase 28025-013 (Invitrogen, ThermoFisher Scientific, MA). Quantitative PCR (qRT-PCR) was performed with PlatinumÒ SYBRÒ Green qPCR SuperMix-UDG w-ROX (ThermoFisher Scientific) in triplicates, normalized to GAPDH and/or HPRT in QuantStudio 12k Flex real-time PCR cycler (Life Technologies). Primers targeting the following genes were used (5 0 to 3 0 ): NKG2C: F-AGTACAGGCCAGCAAACTCT, R-CCCCGAATACAAGAACGCAG. CXCR2: F-TCAAAGCTGTCACTCTCCATGT, R-CTGCTCTTCTGGAGGTGTCC. IL-3: F-CTGTTGAATGCCTCCAGGTT, R-CTTTGCCTTTGCTGGACTTC. CLEC1A: F-ACAAAGTCAGCAGGGTCAGG, R-ATGAGCCTGCATTCTCAAGG. CLEC4E: F-TCCCAGTTCAATGGACAACA, R -TTTCAAACCTGTGATGAGAAAAAG. 
ATAC-seq of NKG2C
hi NK cells from decidual and endometrial samples of nulligravidae, primigravidae and multigravidae Samples' isolation, library construction and sequencing NKG2C hi dNK cells purified from pooled decidua samples (4 for primigravid and 7 for multigravid) were sorted (confirmed by staining with anti CD56 and anti NKG2C antibodies). The same was done with pooled nulligravid and multigravid endometrial NKG2C hi cells.
In multigravid dNK cells also NKG2C neg cells were sorted. All epidemiological details of these samples are mentioned in Tables S5  and S9 . Cells from each population (5*10 5 ) were used for the ATAC-seq assay. The cells were centrifuged at 500 g for 3 min, followed by a washing step. Cells were lysed using cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 and 0.1% IGEPAL CA-630). Immediately after lysis, nuclei were spun at 500 g for 10 min at 4 C. Next, the pellet was resuspended in the transposase reaction mix (25 mL 2 3 TD buffer, 2.5 mL transposase (Illumina) and 22.5 mL nuclease-free water). The transposition reaction was carried out for 30 min at 37 C. The samples were purified using a QIAGEN MinElute Kit. Following purification, the library fragments were amplified using custom Nextera PCR primers 1 and 2 for a total of 12 cycles. Following PCR amplification, the libraries were purified using a QIAGEN MinElute Kit and sequenced.
50% collagen gel was added on top off the rings and the plate was incubated at 37 C for a further 5-10 minutes. 140ul BIOMPM1 was added to each well, containing 60ul of supernatants collected from growing primigravid or multigravid dNK with or without pre-blocking, and PBS as control. In the blocking experiment, anti hVEGF (Avastin-Bevacizumab 25mg per ml) was added at a concentration of 200ng per ml to supernatants containing 20 ng per ml hVEGF, followed by incubation of 2 hours at 37 C before placed on the rings. Aortic rings were visualized in fluorescent light using a fluorescent microscope ZEISS version Observer. Z1 with a GFP filter, and images were captured using a AxioCam camera and ZEN2012 software. Zoom was set at 2.5X, image size was 1388*1040 pixels, and exposure time 6.4 s. Total length for each group (taking into account number and length of the sprouting capillaries for each ring) was calculated by using ImageJ.
In vivo tumor growth assay Four-week old SCID-Beige female mice (5-6 mice per group) were inoculated subcutaneously with JEG3 cells (2*10 6 cells in 200 mL of PBS). 14 days later, when the tumors became measurable, mice were injected with supernatants obtained from multigravid dNK cells incubated with the various 721.221 transfectants (irradiated with 6000rad), in the presence or absence of the appropriate antibodies. The tumor size was determined by caliper on the next two days and another injection of supernatants was given immediately after the first measurement. In the blocking experiment, anti hVEGF (Avastin-Bevacizumab 25mg per ml) was added at a concentration of 200ng per ml to the supernatants containing 20 ng per ml hVEGF, followed by incubation of 2 hours at 37 C before injection.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are represented as mean ± standard deviation (s.d.). Statistical significance was uniformly set at a minimum of P < 0.05 using Student's t test. 
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